Dr Dawn M. Sievert

Senior Science Advisor on Antimicrobial Resistance, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC) 

Nationality – United States of America 

Dr Dawn Sievert leads the strategic direction, coordination, and investments of CDC’s cross-cutting scientific antimicrobial resistance (AR) activities. Her work supports national goals outlined in the U.S. National Action Plan for Combating Antibiotic-Resistant Bacteria and ensures that AR projects and collaborations across the agency are appropriate and consistent with CDC scientific vision and priorities. As part of this role, Dr. Sievert provides the scientific leadership for CDC’s domestic AR Laboratory Network, CDC’s Global AR Laboratory and Response Network, and the CDC and FDA AR Isolate Bank. She is also Lead of the CDC Collaborating Center within the World Health Organization’s Antimicrobial Resistance Network and has been a contributing member of the WHO STAG-AMR. 

Dr Sievert previously served as the Associate Director for AR in CDC’s Division of Foodborne, Waterborne, and Environmental Diseases and as the Deputy Chief of Surveillance Branch in CDC’s Division of Healthcare Quality Promotion, where she provided scientific leadership for CDC’s National Healthcare Safety Network. 

Prior to CDC, Dr Sievert held roles as the chief scientist within a consulting company focused on new models of electronic automation and health information exchange in medicine and public health; quality improvement and infection control coordinator within a major healthcare system; AR program lead at Michigan’s state health department; and laboratory scientist focused on Alzheimer’s disease and multiple sclerosis research. Dr. Sievert received her PhD in Infectious Disease Epidemiology and BS in Microbiology from the University of Michigan in Ann Arbor, and MS in Epidemiology from the University of Illinois at Chicago.